Henry Schein Names Bridget A. Ross To Lead Global Medical Group

Ms. Ross, 52, will join Henry Schein from Johnson & Johnson, where she spent more than 28 years in sales, marketing and general management roles. At Henry Schein, she will serve as a member of the company's Executive Management Committee (EMC) and report to Karen Prange, Executive Vice President and Chief Executive Officer, Global Animal Health, Medical, and Dental Surgical Group. Ms. Ross's appointment is effective February 14, 2017.

In her new role, Ms. Ross will be responsible for overall leadership of the Global Medical Group, including strategic direction, management, and business performance. In partnership with her team, she will be responsible for the group's sales, marketing, operations, business development, and technology solutions.

"This is a period of transformational change and consolidation in the global medical industry, and Henry Schein is committed to helping lead customers through this transformation for the benefit of their patients," said Stanley M. Bergman, Chairman of the Board and Chief Executive Officer, Henry Schein, Inc. "Bridget has the talent, energy, and experience necessary to successfully manage large organizations during periods of great change. As market, technological, and demographic forces converge to create unique business opportunities for Henry Schein, we are delighted that Bridget will join us to make the most of these opportunities."

Immediately prior to joining Henry Schein, Ms. Ross was Vice President, Commercial Operations, North America, for J&J's Medical Devices Group, a $25 billion business. In this role, she led a commercial operations integration in North America, bringing together three franchises and several National Account Management groups while supporting more than 5,000 commercial employees across multiple businesses. Prior to that assignment, Ms. Ross held roles including Global President of Acclarent Inc. and Global President of Ethicon's Women's Health & Urology, both J&J Medical Device companies. 

"Bridget joins Henry Schein with a significant track record in leading and growing global businesses," said Ms. Prange. "Bridget drove business results and led teams in multiple therapeutic areas, where she consistently demonstrated a passion for people development and innovation. We look forward to Bridget bringing that same passion to Henry Schein as we deepen our investment in the medical industry during this time of tremendous opportunity."

Ms. Ross will work out of Henry Schein's corporate headquarters in Melville, New York.

"I am excited to join Henry Schein, a company with a stellar track record for developing and growing businesses and a unique 'Team Schein' culture," Ms. Ross said. "The company is committed to embracing change as markets evolve, making this an especially momentous time to add to the continued success of Henry Schein. I look forward to playing my part in advancing the work of this great company."

About Henry Schein, Inc.

Henry Schein, Inc. (Nasdaq:HSIC) is the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners. The company also serves dental laboratories, government and institutional health care clinics, and other alternate care sites. A Fortune 500® Company and a member of the S&P 500® and the NASDAQ 100® indexes, Henry Schein employs nearly 19,000 Team Schein Members and serves more than one million customers.

The company offers a comprehensive selection of products and services, including value-added solutions for operating efficient practices and delivering high-quality care. Henry Schein operates through a centralized and automated distribution network, with a selection of more than 110,000 branded products and Henry Schein private-brand products in stock, as well as more than 150,000 additional products available as special-order items. The company also offers its customers exclusive, innovative technology solutions, including practice management software and e-commerce solutions, as well as a broad range of financial services.                                         

Headquartered in Melville, N.Y., Henry Schein has operations or affiliates in 33 countries. The company's sales reached a record $10.6 billion in 2015, and have grown at a compound annual rate of approximately 15 percent since Henry Schein became a public company in 1995. For more information, visit Henry Schein at www.henryschein.com, Facebook.com/HenrySchein and @HenrySchein on Twitter.

SOURCE Henry Schein, Inc.

Related Links

http://www.henryschein.com